What subjective symptoms and physical examination findings are characteristic of serotonin syndrome?

Serotonin Syndrome: Clinical Presentation

Serotonin syndrome presents with a classic triad: mental status changes, autonomic hyperactivity, and neuromuscular abnormalities, typically developing within 6-24 hours of initiating or increasing a serotonergic medication. 1, 2

Common Subjective Findings (Patient-Reported Symptoms)

Patients with serotonin syndrome commonly report:

Most Frequent Initial Complaints

• Dizziness (47% overall; 16% as initial symptom) 3
• Headache (16% as initial symptom) 3
• Tremor (78% of cases) 3

Mental Status Symptoms

• Confusion and agitation 1
• Anxiety 1
• Restlessness and irritability 4
• Insomnia 4

Autonomic Symptoms

• Excessive sweating/diaphoresis 1, 2
• Shivering 1
• Diarrhea 1
• Vomiting 1
• Abdominal discomfort 4

Other Common Complaints

• Gait difficulty (common reason for hospital presentation) 3
• Febrile symptoms 3

Critical timing: Symptoms typically arise within 24-48 hours after combining serotonergic medications or increasing doses, though onset can range from minutes to 24 hours 1, 2.

---

Pertinent Physical Examination Components and Expected Findings

Neuromuscular Examination (Most Diagnostically Important)

Clonus and hyperreflexia are highly diagnostic for serotonin syndrome and their presence with serotonergic drug use essentially establishes the diagnosis 2.

Key Findings:

• Hyperreflexia (exaggerated deep tendon reflexes) 1, 2
• Clonus (rhythmic muscle contractions):
  • Inducible clonus (elicited by rapid dorsiflexion of foot)
  • Spontaneous clonus (occurs without stimulation)
  • Ocular clonus (horizontal eye movements) 2
• Tremor (most common finding - 57% of cases) 2
• Myoclonus (sudden muscle jerks) 2
• Muscle rigidity - particularly affecting lower extremities more than upper extremities 2
• Hypertonia (increased muscle tone) 2

Important distinction: Unlike neuroleptic malignant syndrome which shows "lead pipe" rigidity, serotonin syndrome shows increased tone predominantly in lower extremities with preserved or increased reflexes 2.

Vital Signs Assessment

Temperature

• Elevated (≤41.1°C/106°F) 2
• Severe cases: >41.1°C indicates life-threatening presentation 2

Cardiovascular

• Tachycardia (rapid heart rate) 1, 2
• Hypertension (may deteriorate to hypotension in severe cases) 1, 2
• Supine hypertension with orthostatic hypotension may occur 5
• Arrhythmias in advanced cases 1

Respiratory

• Tachypnea (rapid breathing) 1, 2

Mental Status Examination

• Agitated delirium 2
• Confusion 1
• Altered consciousness ranging from agitation to coma in severe cases 2

Additional Physical Findings

Skin

• Diaphoresis (profuse sweating) 2
• Flushed appearance

Eyes

• Mydriasis (dilated pupils) 2

Oral/GI

• Sialorrhea (excessive salivation) 2
• Hyperactive bowel sounds 2

---

Diagnostic Approach Using Hunter Criteria

The Hunter Criteria have superior sensitivity (84%) and specificity (97%) compared to older Sternbach criteria 2. Diagnosis requires serotonergic drug use within the last 5 weeks PLUS any of the following:

1. Spontaneous clonus alone
2. Inducible clonus + (agitation OR diaphoresis)
3. Ocular clonus + (agitation OR diaphoresis)
4. Tremor + hyperreflexia
5. Hypertonia + temperature >38°C + (ocular clonus OR inducible clonus)

2, 6

---

Critical Clinical Pitfalls

Don't Miss These Red Flags for Severe Disease:

• Temperature >41.1°C 2
• Muscle rigidity with hyperthermia (risk of rhabdomyolysis) 2
• Altered consciousness progressing to coma 1
• Seizures 2

Common Misdiagnosis Traps:

The presentation overlaps significantly with other drug toxicity syndromes. Key differentiating features from neuroleptic malignant syndrome: serotonin syndrome has hyperreflexia and clonus (vs. bradyreflexia in NMS), faster onset (hours vs. days), and lower extremity predominance of rigidity 2.

Medication History is Essential:

Always inquire about recent additions or dose changes of: SSRIs, SNRIs, MAOIs, tramadol, fentanyl, meperidine, linezolid, dextromethorphan, St. John's Wort, and illicit drugs (MDMA, cocaine, methamphetamine) 1, 2, 7.

The mortality rate is approximately 11%, making prompt recognition critical 2.